CHRISTEN CRAIG: Open Payments
NPI 1407389232 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,483 in 252 payments from 20 companies in 2025. Trend: 2023 $2,188 · 2024 $3,202 · 2025 $5,483
Food & beverage: $5,483
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 51 | $1,043 |
| Janssen Biotech, Inc. | 26 | $757 |
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $456 |
| Lilly USA, LLC | 20 | $412 |
| Madrigal Pharmaceuticals | 22 | $395 |
| Aimmune Therapeutics, Inc. | 16 | $301 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $295 |
| QOL Medical, LLC | 9 | $251 |
| Celltrion USA Inc. | 14 | $250 |
| Regeneron Healthcare Solutions, Inc. | 11 | $210 |
Products named: TREMFYA, RINVOQ, OMVOH, REZDIFFRA, ENTYVIO, DUPIXENT, XIFAXAN, Sucraid.
Industry payments across MO — which companies pay providers there.
